{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:06:41Z","timestamp":1792033601028,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2628,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/modpathol.2015.100","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T07:42:13Z","timestamp":1441352533000},"page":"1448-1457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications"],"prefix":"10.1016","volume":"28","author":[{"given":"Leonardo","family":"Boiocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Gianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Iurlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bonzheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2015.100_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"40","author":"Thiele","year":"2008"},{"key":"10.1038\/modpathol.2015.100_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.seminhematol.2005.05.020","article-title":"Bone marrow histopathology in myeloproliferative disorders\u2014current diagnostic approach","volume":"42","author":"Thiele","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1038\/modpathol.2015.100_bib3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2013-06-508416","article-title":"Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis","volume":"122","author":"Silver","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clml.2014.11.002","article-title":"Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"15","author":"Pozdnyakova","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1038\/modpathol.2015.100_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.leu.2404914","article-title":"Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment","volume":"22","author":"Barosi","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.100_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/modpathol.2013.109","article-title":"Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage","volume":"26","author":"Boiocchi","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.100_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/modpathol.2012.165","article-title":"Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease","volume":"26","author":"Boiocchi","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.100_bib8","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","article-title":"The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features","volume":"22","author":"Orazi","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.100_bib9","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"76","author":"Orazi","year":"2008"},{"key":"10.1038\/modpathol.2015.100_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bjh.12117","article-title":"Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients","volume":"160","author":"Bonicelli","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.100_bib11","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.100_bib12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2009-02-206797","article-title":"Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?","volume":"114","author":"Barbui","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2005.05.023","article-title":"Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils","volume":"42","author":"Falanga","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1038\/modpathol.2015.100_bib14","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.100_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-62703-357-2_3","article-title":"Laboratory detection of JAK2V617F in human myeloproliferative neoplasms","volume":"999","author":"Kui","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1038\/modpathol.2015.100_bib16","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.humpath.2014.08.014","article-title":"The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia","volume":"45","author":"Federmann","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.100_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"10.1038\/modpathol.2015.100_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2141.2007.06674.x","article-title":"Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation","volume":"138","author":"Gangat","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.100_bib19","series-title":"Juvenile Myelomonocytic Leukaemia, In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"82","author":"Baumann","year":"2008"},{"key":"10.1038\/modpathol.2015.100_bib20","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"32","author":"Vardiman","year":"2008"},{"key":"10.1038\/modpathol.2015.100_bib21","series-title":"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"80","author":"Vardiman","year":"2008"},{"key":"10.1038\/modpathol.2015.100_bib22","series-title":"Myelodysplastic\/Myeloproliferative Neoplasm, Unclassifiable, In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"85","author":"Vardiman","year":"2008"},{"key":"10.1038\/modpathol.2015.100_bib23","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2013.122","article-title":"CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.100_bib24","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2015.100_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MOH.0000000000000014","article-title":"The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy","volume":"21","author":"Elliott","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/modpathol.2015.100_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia","volume":"45","author":"Piazza","year":"2013","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2015.100_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bjh.12491","article-title":"Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression","volume":"163","author":"Fernandez-Mercado","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.100_bib28","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/leu.2013.97","article-title":"SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML","volume":"27","author":"Laborde","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.100_bib29","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","article-title":"SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)","volume":"120","author":"Meggendorfer","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3324\/haematol.2013.095133","article-title":"SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes","volume":"99","author":"Hanssens","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.100_bib31","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1182\/blood-2011-11-390252","article-title":"Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib32","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood-2012-02-412296","article-title":"The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution","volume":"120","author":"Wu","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib33","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias","volume":"121","author":"Itzykson","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib34","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2009-08-236596","article-title":"Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm","volume":"115","author":"Beer","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib35","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2006-12-061135","article-title":"Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation","volume":"109","author":"Hussein","year":"2007","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.100_bib36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood-2008-01-136499","article-title":"Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L\/JAK2V617F mutation","volume":"113","author":"Hussein","year":"2009","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:47:53Z","timestamp":1760230073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222013540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0893395222013540"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2015.100","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2015.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}